80322 Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 

Dated: November 14, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–25464 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neurodegenerative Disorders and Aging. 

Date: December 6, 2023. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jessica Bellinger, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3158, 

Bethesda, MD 20892, (301) 827–4446, 

bellingerjd@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: November 14, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–25465 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel Clinical 

Trials Planning Program. 

Date: January 23, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W106, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Eduardo Emilio Chufan, 

Ph.D. Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W106, Rockville, Maryland 

20850 240–276–7975, chufanee@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Metastasis 

Research Network (U01). 

Date: February 1, 2024. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W606, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Bruce Daniel Hissong, 

Ph.D. Scientific Review Officer, Resource and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W606 Rockville, Maryland 20850, 

240–276–7752, bruce.hissong@nih.gov. 

Name of Committee: National Cancer 

Institute, Special Emphasis Panel, Diet, Lipid 

Metabolism, and Tumor Growth and 

Progression. 

Date: February 1, 2024. 

Time: 9:30 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, Maryland 20850 (Virtual 

Meeting). 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248, Rockville, 

Maryland 20850, 240–672–6175, singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute, Special Emphasis, Panel SEP–4: 

NCI Clinical and Translational Cancer 

Research. 

Date: February 6–7, 2024. 

Time: 10:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W264, Rockville, Maryland 20850, (Virtual 

Meeting). 

Contact Person: Ombretta Salvucci, 

Ph.D.,Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W264, 

Rockville, Maryland 20850, 240–276–7286, 

salvucco@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis, Panel SEP–1: NCI 

Clinical and Translational Cancer Research. 

Date: February 7, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W108, Rockville, Maryland 20850, (Virtual 

Meeting). 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Rockville, Maryland 20850, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI SPORE 

(P50) Review SEP–I. 

Date: February 15–16, 2024. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W244, Rockville, Maryland 20850, (Virtual 

Meeting). 

Contact Person: John Paul Cairns, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W244, 

Rockville, Maryland 20850, 301–461–0303, 

paul.cairns@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel NCI 

Outstanding Investigator Award (R35). 

Date: February 15–16, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W104, Rockville, Maryland 20850, (Virtual 

Meeting). 

Contact Person: David G. Ransom, Ph.D., 

Chief, Scientific Review Officer, Special 


khammond on DSKJM1Z7X2PROD with NOTICES